Development of “Intelligent particles” for the treatment of dental caries
European Journal of Pharmaceutics and Biopharmaceutics · 2024
DOI: 10.1016/j.ejpb.2024.114374 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024. Verfasst von Yanping He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Adelaide Dental School, University of Adelaide, Adelaide, SA 5000, Australia. Hauptthemen laut MEDLINE: Dental Caries, Biofilms, Streptococcus mutans, Silver. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Dental Research Foundation Inc, National Health and Medical Research Council, University of Adelaide.
Abstract (Originalsprache)
Dental caries is one of the most prevalent non-communicable diseases worldwide, mediated by a multispecies biofilm that consists of high levels of acidogenic bacteria which ferment sugar to acid and cause teeth demineralization. Current treatment practice remains insufficient in addressing 1) rapid clearance of therapeutic agents from the oral environment 2) destroying bacteria that contribute to the healthy oral microbiome. In addition, increasing concerns over antibiotic resistance calls for innovative alternatives. In this study, we developed a pH responsive nano-carrier for delivery of polycationic silver nanoparticles. Branched-PEI capped silver nanoparticles (BPEI-AgNPs) were encapsulated in a tannic acid - Fe (III) complex-modified poly(D,L-lactic-co-glycolic acid) (PLGA) particle (Fe(III)-TA/PLGA@BPEI-AgNPs) to enhance binding to the plaque biofilm and demonstrate "intelligence" by releasing BPEI-AgNPs under acidic conditions that promote dental caries The constructed Fe(III)-TA/PLGA@BPEI-AgNPs (intelligent particles - IPs) exhibited significant binding to an axenic S. mutans biofilm grown on hydroxyapatite. Ag+ ions were released faster from the IPs at pH 4.0 (cariogenic pH) compared to pH 7.4. The antibiofilm results indicated that IPs can significantly reduce S. mutans biofilm volume and viability under acidic conditions. Cytotoxicity on differentiated Caco-2 cells and human gingival fibroblasts indicated that IPs were not cytotoxic. These findings demonstrate great potential of IPs in the treatment of dental caries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adelaide Dental School, University of Adelaide, Adelaide, SA 5000, Australia.
- College of Medicine and Public Health, Flinders University, Bedford Park SA 5042, Australia.
- Adelaide Dental School, University of Adelaide, Adelaide, SA 5000, Australia. Electronic address: peter.zilm@adelaide.edu.au.
Förderung
- Australian Dental Research Foundation Inc
- National Health and Medical Research Council
- University of Adelaide
- International Association for Dental Oral and Craniofacial Research
Zitieren
APA
He, Y., Bright, R., Vasilev, K., & Zilm, P. (2024). Development of “Intelligent particles” for the treatment of dental caries. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2024.114374
Vancouver
He Y, Bright R, Vasilev K, Zilm P. Development of “Intelligent particles” for the treatment of dental caries. European Journal of Pharmaceutics and Biopharmaceutics. 2024. doi:10.1016/j.ejpb.2024.114374
BibTeX
@article{He2024,
author = {He, Yanping and Bright, Richard and Vasilev, Krasimir and Zilm, Peter},
title = {Development of “Intelligent particles” for the treatment of dental caries},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2024},
doi = {10.1016/j.ejpb.2024.114374}
}
EUVIMED